PubMed:10339482 / 653-824
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T23 | 0-10 | protein | denotes | PI3-kinase |
| T24 | 49-56 | protein | denotes | PKB/Akt |
| T25 | 69-79 | protein | denotes | PI3-kinase |
| T26 | 125-132 | protein | denotes | PKB/Akt |
| T27 | 154-161 | protein | denotes | PKB/Akt |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S5 | 0-171 | Sentence | denotes | PI3-kinase activity was an upstream activator of PKB/Akt because the PI3-kinase inhibitor LY294002 blocked both constitutive PKB/Akt and factor-dependent PKB/Akt activity. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C14 | 49-56 | NP | denotes | PKB/Akt |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 0-10 | protein_molecule | denotes | PI3-kinase |
| T27 | 49-56 | protein_molecule | denotes | PKB/Akt |
| T28 | 69-79 | protein_molecule | denotes | PI3-kinase |
| T29 | 90-98 | other_organic_compound | denotes | LY294002 |
| T30 | 112-124 | other_name | denotes | constitutive |
| T31 | 125-132 | protein_molecule | denotes | PKB/Akt |
| T32 | 137-153 | other_name | denotes | factor-dependent |
| T33 | 154-161 | protein_molecule | denotes | PKB/Akt |